PULMONARY FIBROSISWhat is Pulmonary Fibrosis?Pulmonary fibrosis is an abnormal formation of fibre-like scar tissue in the alveoli (air sacs which take oxygen to the lungs and expel carbon dioxide) and interstitial tissue (the tissues between and surrounding the alveoli) of the lungs. It is a chronic lung disease associated with inflammation. Inhaling small particles can cause damage to the alveoli. Pulmonary fibrosis occurs when the alveoli gradually become replaced by fibrotic tissue. This leads to scarring, which makes the lung tissue thicker and causes an irreversible loss of the tissue’s ability to transfer oxygen into the bloodstream. Pulmonary fibrosis can be a mild, severe or even life-threatening disease. If the disease progresses the lung tissues eventually thicken and become stiff, leading to breathlessness and difficulty breathing.Symptoms
CausesThe causes of the condition “idiopathic (of unknown origin) pulmonary fibrosis” are not known. However there are over 140 causes or associations with pulmonary fibrosis. A reaction to a microscopic injury or irritation in the lung causing inflammation appears to be one of the causes of pulmonary fibrosis. Although doctors may claim that pulmonary fibrosis is due to a given disease, such as sarcoidosis, the specific causes of those particular diseases may also be unknown. In addition there is a growing body of evidence which points to a genetic predisposition. Families with a history of pulmonary fibrosis have been found to have a mutation in the SP-C protein. Although the exact cause of pulmonary fibrosis remains unknown, associations have been made with the following:
DiagnosisA number of different diagnostic techniques are used to diagnose pulmonary fibrosis. Indicators which may point towards a patient having pulmonary fibrosis include:
PrognosisThe outcomes of pulmonary fibrosis differ for each individual. In many cases pulmonary fibrosis remains mild and takes a number of years to slowly progress. However, in other cases pulmonary fibrosis may be due to underlying diseases such as rheumatoid arthritis. These underlying diseases may progress and affect the pulmonary fibrosis itself. Pulmonary fibrosis tends to result in a slow progressive scarring of the lungs. Unfortunately some patients do not respond positively to therapy and their lungs will slowly deteriorate over a period of months or years until they are no longer able to function adequately. Alternatively other patients have a positive response to therapy. The duration and speed of the onset of pulmonary fibrosis differs on a case by case basis. TreatmentIf one of the known causes of pulmonary fibrosis exists then that underlying disease can be treated in order to limit the inflammation in the lungs. Limited inflammation will prevent the formation of scar tissue in the lungs and hopefully stop the progression of pulmonary fibrosis. However, due to the lack of standard diagnostic criteria, no effective treatments or a cure for pulmonary fibrosis currently exist. Supplemental oxygen can be administered in order to treat breathlessness and to improve a patient’s quality of life and exercise capacity. Removing the patient from the environment in which pollutants are being inhaled can also assist in limiting the progression of the disease. Chest infections require early treatment. Some patients may be considered for a single lung transplant. In addition, patients must quit smoking, as tobacco aggravates shortness of breath. |
| | | | | | | | | |
Location: http://www.liwa.uwa.edu.au/page/3986
Page Information | Printer Friendly Version